18Fluorodeoxyglucose Accumulation in Arterial Tissues Determined by PET Signal Analysis.

BACKGROUND Arterial 18fluorodeoxyglucose (FDG) positron emission tomography (PET) is considered a measure of atherosclerotic plaque macrophages and is used for quantification of disease activity in clinical trials, but the distribution profile of FDG across macrophages and other arterial cells has not been fully clarified. OBJECTIVES The purpose of this study was to analyze FDG uptake in different arterial tissues and their contribution to PET signal in normal and atherosclerotic arteries. METHODS Wild-type and D374Y-PCSK9 transgenic Yucatan minipigs were fed a high-fat, high-cholesterol diet to induce atherosclerosis and subjected to a clinical FDG-PET and computed tomography scan protocol. Volumes of arterial media, intima/lesion, macrophage-rich, and hypoxic tissues were measured in serial histological sections. Distributions of FDG in macrophages and other arterial tissues were quantified using modeling of the in vivo PET signal. In separate transgenic minipigs, the intra-arterial localization of FDG was determined directly by autoradiography. RESULTS Arterial FDG-PET signal appearance and intensity were similar to human imaging. The modeling approach showed high accuracy in describing the FDG-PET signal and revealed comparable FDG accumulation in macrophages and other arterial tissues, including medial smooth muscle cells. These findings were verified directly by autoradiography of normal and atherosclerotic arteries. CONCLUSIONS FDG is taken up comparably in macrophage-rich and -poor arterial tissues in minipigs. This offers a mechanistic explanation to a growing number of observations in clinical imaging studies that have been difficult to reconcile with macrophage-selective FDG uptake.

[1]  A. Murray,et al.  Comparison of fluorodeoxyglucose uptake in symptomatic carotid artery and stable femoral artery plaques , 2014, The British journal of surgery.

[2]  Z. Fayad,et al.  Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study. , 2013, Journal of the American College of Cardiology.

[3]  J. Seward,et al.  Independent Association of High Blood Pressure and Aortic Atherosclerosis: A Population-Based Study , 2000, Circulation.

[4]  Ahmed Tawakol,et al.  Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial , 2011, The Lancet.

[5]  L. Tolbod,et al.  Quantitative applications in positron emission tomography achieved through signal modelling. , 2019, American journal of nuclear medicine and molecular imaging.

[6]  Z. Fayad,et al.  The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial. , 2015, Atherosclerosis.

[7]  E. Falk,et al.  Diabetes with poor glycaemic control does not promote atherosclerosis in genetically modified hypercholesterolaemic minipigs , 2015, Diabetologia.

[8]  Lars Bolund,et al.  Familial Hypercholesterolemia and Atherosclerosis in Cloned Minipigs Created by DNA Transposition of a Human PCSK9 Gain-of-Function Mutant , 2013, Science Translational Medicine.

[9]  Diederik F Van Wijk,et al.  Nonpharmacological lipoprotein apheresis reduces arterial inflammation in familial hypercholesterolemia. , 2014, Journal of the American College of Cardiology.

[10]  V. Fuster,et al.  Optimizing 18F-FDG PET/CT imaging of vessel wall inflammation: the impact of 18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[11]  R. Virmani,et al.  Mechanisms of Plaque Formation and Rupture , 2014 .

[12]  R L Williams,et al.  A Note on Robust Variance Estimation for Cluster‐Correlated Data , 2000, Biometrics.

[13]  Ahmed Tawakol,et al.  In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. , 2006, Journal of the American College of Cardiology.

[14]  J. Pickard,et al.  Imaging Atherosclerotic Plaque Inflammation With [18F]-Fluorodeoxyglucose Positron Emission Tomography , 2002, Circulation.

[15]  E. Falk,et al.  Mechanisms of Plaque Formation and Rupture , 2014 .

[16]  J. Rudd,et al.  PET imaging of inflammation in atherosclerosis , 2014, Nature Reviews Cardiology.

[17]  Z. Fayad,et al.  Noninvasive Molecular Imaging of Disease Activity in Atherosclerosis , 2016, Circulation research.

[18]  I. Buvat,et al.  Partial-Volume Effect in PET Tumor Imaging* , 2007, Journal of Nuclear Medicine.

[19]  H. Marquering,et al.  Thresholds for Arterial Wall Inflammation Quantified by 18F-FDG PET Imaging , 2016, JACC. Cardiovascular imaging.

[20]  R. Virmani,et al.  Morphological characteristics of coronary atherosclerosis in diabetes mellitus. , 2006, The Canadian journal of cardiology.

[21]  V. Fuster,et al.  (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. , 2007, Journal of the American College of Cardiology.

[22]  Z. Fayad,et al.  A phase 2 randomized, double-blind, placebo-controlled study of the effect of VIA-2291, a 5-lipoxygenase inhibitor, on vascular inflammation in patients after an acute coronary syndrome. , 2015, Atherosclerosis.

[23]  B. Geršak,et al.  Identification of Inflamed Atherosclerotic Lesions In Vivo Using PET-CT , 2013, Inflammation.

[24]  V. Fuster,et al.  Muramidase: A useful monocyte/macrophage immunocytochemical marker in swine, of special interest in experimental cardiovascular disease. , 1994, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[25]  A. Alavi,et al.  Delayed 18F-fluorodeoxyglucose PET/CT imaging improves quantitation of atherosclerotic plaque inflammation: Results from the CAMONA study , 2014, Journal of Nuclear Cardiology.

[26]  P. Libby,et al.  Hypoxia but not inflammation augments glucose uptake in human macrophages: Implications for imaging atherosclerosis with 18fluorine-labeled 2-deoxy-D-glucose positron emission tomography. , 2011, Journal of the American College of Cardiology.

[27]  Mathijs Groeneweg,et al.  Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. , 2008, Journal of the American College of Cardiology.

[28]  A. Alavi,et al.  FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[29]  J. Shim,et al.  Large animal models of atherosclerosis – new tools for persistent problems in cardiovascular medicine , 2016, The Journal of pathology.